Evidence map›Paper›PMID 23312232›Full record

Trial reportFertility and sterility2013

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).

Erin Foran Wolff, Yunxiao He, Dennis M Black, Eliot A Brinton, Mathew J Budoff, Marcelle I Cedars, Howard N Hodis, Rogerio A Lobo, Joann E Manson, George R Merriam and 7 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Fertility and sterility, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00154180 (Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00154180 phase4unknown statusnot on this map

Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women

TypeinterventionalSponsorKronos Longevity Research InstituteRan2005 to 2012Enrolled728ConditionsMenopause, ArteriosclerosisArmsConjugated equine estrogens 0.45 mg/day, Transdermal estradiol, 50 mcg/day, Micronized progesterone, 200 mg/day x 12 d/month, CEE , progesterone, estradiol patch or placebo for each, CEE, progesterone, transdermal patch or the placebo
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 61 citations in OpenAlex.

  1. Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies.Climacteric : the journal of the International Menopause Society · 2024
    Review
  2. Vasomotor symptoms and their links to cardiovascular disease risk.Current opinion in endocrine and metabolic research · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Review of menopausal palpitations measures.Women's midlife health · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Post-reproductive Health: Window of Opportunity for Preventing Comorbidities.Journal of obstetrics and gynaecology of India · 2019
    Article
  11. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.Climacteric : the journal of the International Menopause Society · 2018
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ischemic heart disease in women: a focus on risk factors.Trends in cardiovascular medicine · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 3 countries.

Erin Foran WolffProgram in Reproductive and Adult Endocrinology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA. wolffe@mail.nih.gov
Yunxiao He
Dennis M Black
Eliot A Brinton
Mathew J Budoff
Marcelle I Cedars
Howard N Hodis
Rogerio A Lobo
Joann E Manson
George R Merriam
Virginia M Miller
Fredrick Naftolin
Lubna Pal
Nanette Santoro
Heping Zhang
S Mitchell Harman
Hugh S Taylor
Yale University · USUniversity of San Francisco · USColumbia University · USHarvard University · USKronos Longevity Research Institute · USMayo Clinic · USNational Institutes of Health · USNew York University · USUniversity of California, Los Angeles · USUniversity of Colorado Denver · USUniversity of Southern California · USUniversity of Utah · USUniversity of Washington · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
MAYO CLINIC CENTER FOR TRANSLATIONAL SCIENCE ACTIVITIESUL1RR024150 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$66.4M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Data Coordination Center for the RMNU10HD055925 · NICHD · YALE UNIVERSITY · PI ZHANG, HEPING · 2007 to 2019
$39.2M
Statistical Methods in Genetic Studies of Substance UseR01DA016750 · NIDA · YALE UNIVERSITY · PI ZHANG, HEPING · 2004 to 2016
$3.3M
Estrogen, Platelets, and ArtherosclerosisR01HL090639 · NHLBI · MAYO CLINIC ROCHESTER · PI BAILEY, KENT R, MILLER, VIRGINIA M · 2008 to 2012
$1.9M
Endometrial Derivation in a Human and Macaque Chimeric Bone Marrow ModelZIAHD008925 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI WOLFF, ERIN · 2012 to 2013
$60k
Jaw-Tumor Hyperparathyroidism Syndrome as Reproductive Disease ModelZIAHD008924 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI WOLFF, ERIN · 2012 to 2013
$33k
Intramural NIH HHS Z99 DA999999Intramural NIH HHS Z99 HD999999Intramural NIH HHS Z99 HL999999Intramural NIH HHS Z99 MH999999Intramural NIH HHS Z99 OD999999NCRR NIH HHS 1 UL1 RR024150NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1 RR024150NHLBI NIH HHS HL90639NHLBI NIH HHS R01 HL090639NICHD NIH HHS U10 HD055925NICHD NIH HHS U10HD55925NIDA NIH HHS R01 DA016750NIDA NIH HHS R01DA016750
6 · The paper itself

Abstract

objectiveTo determine whether self-reported menopausal symptoms are associated with measures of subclinical atherosclerosis.

designCross-sectional analysis.

settingMulticenter, randomized controlled trial. PATIENT(S): Recently menopausal women (n = 868) screened for the Kronos Early Estrogen Prevention Study (KEEPS). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Baseline menopausal symptoms (hot flashes, dyspareunia, vaginal dryness, night sweats, palpitations, mood swings, depression, insomnia, irritability), serum E2 levels, and measures of atherosclerosis were assessed. Atherosclerosis was quantified using coronary artery calcium (CAC) Agatston scores (n = 771) and carotid intima-media thickness (CIMT). Logistic regression model of menopausal symptoms and E2 was used to predict CAC. Linear regression model of menopausal symptoms and E2 was used to predict CIMT. Correlation between length of time in menopause with menopausal symptoms, E2, CAC, and CIMT were assessed. RESULT(S): In early menopausal women screened for KEEPS, neither E2 nor climacteric symptoms predicted the extent of subclinical atherosclerosis. Palpitations and depression approached significance as predictors of CAC. Other symptoms of insomnia, irritability, dyspareunia, hot flashes, mood swings, night sweats, and vaginal dryness were not associated with CAC. Women with significantly elevated CAC scores were excluded from further participation in KEEPS; in women meeting inclusion criteria, neither baseline menopausal symptoms nor E2 predicted CIMT. Years since menopause onset correlated with CIMT, dyspareunia, vaginal dryness, and E2. CONCLUSION(S): Self-reported symptoms in recently menopausal women are not strong predictors of subclinical atherosclerosis. Continued follow-up of this population will be performed to determine whether baseline or persistent symptoms in the early menopause are associated with progression of cardiovascular disease. CLINICAL TRIAL REGISTRATION NUMBER: NCT00154180.

Indexed as

Carotid Intima-Media ThicknessAdultCarotid Artery DiseasesCohort StudiesCoronary Artery DiseaseDisease ProgressionDyspareuniaEstrogen Replacement TherapyEstrogensFemaleFollow-Up StudiesHot FlashesHumansLongitudinal StudiesMenopauseMiddle AgedEstrogens

Identifiers

PMID23312232
PMCPMC3615128
OpenAlexW2166189204

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.